Human Health Division (HHD) Products

Product List by Generic Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Doxofylline

Composition
Filodox SR Tablet: Each sustained release tablet contains Doxofylline INN 400
mg.
Filodox 400 Tablet: Each film coated tablet contains Doxofylline INN 400 mg.
Filodox 200 Tablet: Each film coated tablet contains Doxofylline INN 200 mg.
Filodox 100 ml Syrup: Each 5 ml syrup contains Doxofylline INN 100 mg.
Pharmacology
Filodox (Doxofylline) is a novel bronchodilator. It structurally differs from
Theophylline due to presence of a dioxolane group in position 7. Doxofylline
selectively inhibits phosphodiesterase-4 thereby relaxes bronchial smooth
muscle. However, differently from Theophylline, Doxophylline appears to have
decreased affinities toward adenosine A1 and A2 receptors, which may account
for the better safety profile of the drug. Doxofylline is reported to inhibit platelet
activating factor (PAF) and leukotriene production.
Indications
Filodox (Doxofylline) is used to treat COPD, asthma and bronchospasm.
Dosage and Administration
Elderly: 200 mg Tablet two or three times daily.
Adults: 400 mg Tablet two or three times daily or as prescribed by physician.
Children 6 years over: 6 mg/ kg body weight two or three times daily.
If daily required dose of Doxofylline is 400 mg, then Filodox SR Tablet to be
taken once daily or as directed by the physician.

Dextromethorphan + Levomenthol + Diphenhydram

Composition:
Pires™-D Syrup: Each 5 ml syrup contains Dextromethorphan Hydrobromide BP 6.5 mg, Levomenthol BP 2 mg and Diphenhydramine Hydrochloride BP 14 mg.

Indication:
Pires™-D Syrup is indicated as an antitussive, for the relief of persistent, dry, irritating cough, and aiding restful sleep.

Dose & Administration:
Adults and children over 12 years: 2 teaspoonful syrup 4 times a day or as directed by the physicians. Do not take more than 8 teaspoonful syrup in 24 hours.

Domperidon

Composition:
Vomitop Tablet: Each film coated tablet contains Domperidone maleate BP equivalent to 10 mg Domperidone.

Indication:
Prevention & symptomatic relief of acute nausea and vomiting of adults (from any cause specially due to cytotoxic therapy & radiotherapy).Nausea & vomiting associated with L-dopa and bromocriptine treatment for parkinsonian patients. Nausea & vomiting due to migraine, head injury, pancreatitis,gastritis, hepatitis, post-gastrectomy syndrome, haemodialysis and dysmenorrhoea. Non ulcer dyspepsia, oesophageal reflux, reflux oesophagitis & gastritis. Speeding of barium transit in 'follow through' radiological studies.

Dose & Administration:
The recommended dosage for Adult & Elderly patients: 10-20 mg every 4-8 hours. Domperidone should be taken 15-30 minutes before meal. Or as directed by the physician

Desloratadine

COMPOSITION :
Desatrol™Tablet : Each film coated tablet contains Desloratadine BP 5 mg.
Desatrol™Syrup : Each 5 ml syrup contains Desloratadine BP 2.5 mg.

INDICATION :
Allergic Rhinitis: Desatrol™ is indicated for the relief of the nasal and nonnasal symptoms of allergic rhinitis (seasonal and perennial).
Chronic idiopathic Urticaria: Desatrol™ is indicated for the symptomatic relief of pruritus, reduction in the number of hives and size of hives, in patients with chronic idiopathic urticaria.
DOSE AND ADMINISTRATION :
Tablet : In adults and children 12 years of age and over, the recommended dose is 5 mg once daily.
In patients with liver or renal impairment, a starting dose of one 5 mg tablet every other day is recommended.
Syrup : Children 2-5 years of age : 2.5 ml once daily, 6-11 years of age : 5 ml once daily. Adults and children 12 years of age and over : 10 ml once daily. It may be administered with or without food. Or as directed by the physician.


Dexlansoprazole

Composition
Dextac™30 Capsule:Each capsule contains Dexlansoprazole INN 30 mg as enteric coated pellets. 
Dextac™60 Capsule:Each capsule contains Dexlansoprazole INN 60 mg as enteric coated pellets. 

Indication
• Healing of Erosive Esophagitis: Dextac™ (Dexlansoprazole) is indicated for healing of all grades of Erosive Esophagitis (EE) for up to 8 weeks. 
• Maintenance of Healed Erosive Esophagitis: Dextac™  (Dexlansoprazole) is indicated to maintain healing of EE and relief of heartburn for up to 6 months. 
• Symptomatic Non-Erosive Gastroesophageal Reflux Disease: Dextac™ (Dexlansoprazole) is indicated for the treatment of heartburn associated with symptomatic Non-Erosive Gastroesophageal Reflux Disease (GERD) for upto 4 weeks.

Dose & Administration
Important Administration Information
• Dextac™ (Dexlansoprazole) can be taken without regard to food or the timing of food. 
• Dextac™ (Dexlansoprazole) should be swallowed whole.
Alternatively, Dextac™ (Dexlansoprazole) capsules can be administered as follows: 
- Open capsule.
- Sprinkle intact granules on one table spoon.
- Swallow immediately. Granules should not be chewed.
Missed Dose: If a capsule is missed at its usual time, it should be taken as soon as possible. But 
if it is too close to the time of the next dose, only the prescribed dose should be taken at the 
appointed time. A double dose should not be taken. or as directed by the physicians.